These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 17091247)

  • 61. Phenotype conversion from rheumatoid arthritis to systemic lupus erythematosus by introduction of Yaa mutation into FcγRIIB-deficient C57BL/6 mice.
    Kawano S; Lin Q; Amano H; Kaneko T; Nishikawa K; Tsurui H; Tada N; Nishimura H; Takai T; Shirai T; Takasaki Y; Hirose S
    Eur J Immunol; 2013 Mar; 43(3):770-8. PubMed ID: 23280344
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In silico analysis of autoimmune diseases and genetic relationships to vaccination against infectious diseases.
    McGarvey PB; Suzek BE; Baraniuk JN; Rao S; Conkright B; Lababidi S; Sutherland A; Forshee R; Madhavan S
    BMC Immunol; 2014 Dec; 15():61. PubMed ID: 25486901
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Preventing intense false positive and negative reactions attributed to the principle of ELISA to re-investigate antibody studies in autoimmune diseases.
    Terato K; Do CT; Cutler D; Waritani T; Shionoya H
    J Immunol Methods; 2014 May; 407():15-25. PubMed ID: 24681241
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Fcgamma and complement receptors: expression, role and co-operation in mediating the oxidative burst and degranulation of neutrophils of Brazilian systemic lupus erythematosus patients.
    Marzocchi-Machado CM; Alves CM; Azzolini AE; Polizello AC; Carvalho IF; Lucisano-Valim YM
    Lupus; 2002; 11(4):240-8. PubMed ID: 12043888
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Elucidating the interplay between IgG-Fc valency and FcγR activation for the design of immune complex inhibitors.
    Ortiz DF; Lansing JC; Rutitzky L; Kurtagic E; Prod'homme T; Choudhury A; Washburn N; Bhatnagar N; Beneduce C; Holte K; Prenovitz R; Child M; Killough J; Tyler S; Brown J; Nguyen S; Schwab I; Hains M; Meccariello R; Markowitz L; Wang J; Zouaoui R; Simpson A; Schultes B; Capila I; Ling L; Nimmerjahn F; Manning AM; Bosques CJ
    Sci Transl Med; 2016 Nov; 8(365):365ra158. PubMed ID: 27856797
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The role of FcgammaRIIA and IIIA polymorphisms in autoimmune diseases.
    Karassa FB; Trikalinos TA; Ioannidis JP
    Biomed Pharmacother; 2004 Jun; 58(5):286-91. PubMed ID: 15194164
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Fc-gamma receptor polymorphisms differentially influence susceptibility to systemic lupus erythematosus and lupus nephritis.
    Tsang-A-Sjoe MW; Nagelkerke SQ; Bultink IE; Geissler J; Tanck MW; Tacke CE; Ellis JA; Zenz W; Bijl M; Berden JH; de Leeuw K; Derksen RH; Kuijpers TW; Voskuyl AE
    Rheumatology (Oxford); 2016 May; 55(5):939-48. PubMed ID: 26748351
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort.
    Alarcón-Segovia D; Alarcón-Riquelme ME; Cardiel MH; Caeiro F; Massardo L; Villa AR; Pons-Estel BA;
    Arthritis Rheum; 2005 Apr; 52(4):1138-47. PubMed ID: 15818688
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Induction of tolerogenic dendritic cells by NF-κB blockade and Fcγ receptor modulation.
    Carreño LJ; Riedel CA; Kalergis AM
    Methods Mol Biol; 2011; 677():339-53. PubMed ID: 20941620
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immune Responses at Host Barriers and Their Importance in Systemic Autoimmune Diseases.
    Schinnerling K; Penny HA; Soto JA; Melo-Gonzalez F
    Adv Exp Med Biol; 2023; 1408():3-24. PubMed ID: 37093419
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Increased expression of Fcgamma receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor alpha and matrix metalloproteinase.
    Blom AB; Radstake TR; Holthuysen AE; Slöetjes AW; Pesman GJ; Sweep FG; van de Loo FA; Joosten LA; Barrera P; van Lent PL; van den Berg WB
    Arthritis Rheum; 2003 Apr; 48(4):1002-14. PubMed ID: 12687542
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Immunoregulation and autoimmunity.
    Stobo JD; Loehnen CP
    Mayo Clin Proc; 1976 Aug; 51(8):479-83. PubMed ID: 7714
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants.
    Dashivets T; Thomann M; Rueger P; Knaupp A; Buchner J; Schlothauer T
    PLoS One; 2015; 10(12):e0143520. PubMed ID: 26657484
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Metabolic alterations of the immune system in the pathogenesis of autoimmune diseases.
    Blanco LP; Kaplan MJ
    PLoS Biol; 2023 Apr; 21(4):e3002084. PubMed ID: 37098006
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Detection of circulating antibodies in the blood and immune complex precipitates of patients with autoimmune diseases (preliminary report)].
    Kiss M; Husz S; Dobozy A
    Orv Hetil; 1992 May; 133(18):1103-4, 1109-10. PubMed ID: 1579350
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bridging autoantibodies and arthritis: the role of Fc receptors.
    el Bannoudi H; Ioan-Facsinay A; Toes RE
    Curr Top Microbiol Immunol; 2014; 382():303-19. PubMed ID: 25116106
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fc gamma receptor biology and systemic lupus erythematosus.
    Jovanovic V; Dai X; Lim YT; Kemeny DM; MacAry PA
    Int J Rheum Dis; 2009 Dec; 12(4):293-8. PubMed ID: 20374365
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Using Poly I:C as an adjuvant does not induce or exacerbate models of systemic lupus erythematosus.
    Annable T; Tomassian T; Jain S; Leibbrandt M; Cooke MP; Deane JA
    Autoimmunity; 2015 Feb; 48(1):29-39. PubMed ID: 25483245
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Correlation research on the expression of FcgammaR II b on B cells and rheumatoid arthritis patients of Shen deficiency syndrome].
    Liao QH; Guo LK; Luo SZ; Lai RG; Liu XL; Chen GX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Sep; 33(9):1203-7. PubMed ID: 24273974
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Novel molecular targets for systemic lupus erythematosus.
    Marino M; Rossi M; Ruvo M; Fassina G
    Curr Drug Targets; 2002 Jun; 3(3):223-8. PubMed ID: 12041736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.